This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Ameni A.Z., Latorre O.A., Torres L.M., Górniak S.L.: Toxicity study about a medicinal plant Casearia sylvestris: A contribution to the Brazilian Unified Health System (SUS). J Ethnopharmacol 2015, 175, 9–13, doi: 10.1016/j.jep.2015.08.027.AmeniA.Z.LatorreO.A.TorresL.M.GórniakS.L.Toxicity study about a medicinal plant Casearia sylvestris: A contribution to the Brazilian Unified Health System (SUS)2015175913doi10.1016/j.jep.2015.08.027Open DOISearch in Google Scholar
Chinsangaram J., Piccone M.E., Grubman M.J.: Ability of foot-and-mouth disease virus to form plaques in cell culture is associated with suppression of alpha/beta interferon. J Virol 1999, 73, 9891–9898, doi: 10.1128/JVI.73.12.9891-9898.1999.ChinsangaramJ.PicconeM.E.GrubmanM.J.Ability of foot-and-mouth disease virus to form plaques in cell culture is associated with suppression of alpha/beta interferon19997398919898doi10.1128/JVI.73.12.9891-9898.1999Open DOISearch in Google Scholar
Dunn G.P., Koebel C.M., Schreiber R.D.: Interferons, immunity and cancer immunoediting. Nat Rev Immunol 2006, 6, 836–848, doi:10.1038/nri1961.DunnG.P.KoebelC.M.SchreiberR.D.Interferons, immunity and cancer immunoediting20066836848doi10.1038/nri1961Open DOISearch in Google Scholar
Edmonson J.H., Kovach J.S., Buckner J.C., Kvols L.K., Hahn R.G.: Phase I study of difluoromethylornithine in combination with recombinant alpha 2a-interferon. Cancer Res 1988, 48, 6584–6586.EdmonsonJ.H.KovachJ.S.BucknerJ.C.KvolsL.K.HahnR.G.Phase I study of difluoromethylornithine in combination with recombinant alpha 2a-interferon19884865846586Search in Google Scholar
Einhorn S., Strander H.: Is interferon tissue specific? Effect of human leukocyte and fibroblast interferons on the growth of lymphoblastoid and osteosarcoma cell lines. J Gen Virol 1977, 35, 573–577, doi: 10.1099/0022-1317-35-3-573.EinhornS.StranderH.Is interferon tissue specific? Effect of human leukocyte and fibroblast interferons on the growth of lymphoblastoid and osteosarcoma cell lines197735573577doi10.1099/0022-1317-35-3-573Open DOISearch in Google Scholar
Goodkin D.E.: Interferon beta therapy for multiple sclerosis. Lancet 1998, 352, 1486–1487, doi: 10.1016/S0140-6736(98)00057-9.GoodkinD.E.Interferon beta therapy for multiple sclerosis199835214861487doi10.1016/S0140-6736(98)00057-9Open DOISearch in Google Scholar
Isaacs A., Lindenmann J.: Virus interference. I. The interferon. Proc R Soc Lond B Biol Sci 1957, 147, 258–267, doi: 10.1098/rspb.1957.0048.IsaacsA.LindenmannJ.Virus interference. I. The interferon1957147258267doi10.1098/rspb.1957.004813465720Open DOISearch in Google Scholar
Kim H.-C., Kang B.-H., Ha C.-S., Han S.-S., Roh J.-K.: An acute toxicity study of recombinant human interferon alpha A (LBD-007) in Sprague-Dawley rats. J Toxicol Sci 1993, 18 Suppl 2, 37–42, doi: 10.2131/jts.18.supplementii_37.KimH.-C.KangB.-H.HaC.-S.HanS.-S.RohJ.-K.An acute toxicity study of recombinant human interferon alpha A (LBD-007) in Sprague-Dawley rats199318Suppl 23742doi10.2131/jts.18.supplementii_378355289Open DOISearch in Google Scholar
Koyama R., Arase Y., Ikeda K., Suzuki F., Suzuki Y., Saitoh S., Kobayashi M., Akuta N., Someya T., Hosaka T., Sezaki H., Kobayashi M., Kumada H.: Efficacy of interferon therapy in elderly patients with chronic hepatitis C. Intervirology 2006, 49, 121–126, doi: 10.1159/000089372.KoyamaR.AraseY.IkedaK.SuzukiF.SuzukiY.SaitohS.KobayashiM.AkutaN.SomeyaT.HosakaT.SezakiH.KobayashiM.KumadaH.Efficacy of interferon therapy in elderly patients with chronic hepatitis C200649121126doi10.1159/00008937216428887Open DOISearch in Google Scholar
Li Y., Zhang X., Liang C., Hu J., Yu Z.: Safety evaluation of mulberry leaf extract: Acute, subacute toxicity and genotoxicity studies. Regul Toxicol Pharmacol 2018, 95, 220–226, doi: 10.1016/j.yrtph.2018.03.007.LiY.ZhangX.LiangC.HuJ.YuZ.Safety evaluation of mulberry leaf extract: Acute, subacute toxicity and genotoxicity studies201895220226doi10.1016/j.yrtph.2018.03.00729530616Open DOISearch in Google Scholar
Marcus P.I., van der Heide L., Sekellick M.J.: Interferon action on avian viruses. I. Oral administration of chicken interferon-alpha ameliorates Newcastle disease. J Interferon Cytokine Res 1999, 19, 881–885, doi: 10.1089/107999099313406.MarcusP.I.van derHeide L.SekellickM.J.Interferon action on avian viruses. I. Oral administration of chicken interferon-alpha ameliorates Newcastle disease199919881885doi10.1089/10799909931340610476933Open DOISearch in Google Scholar
Ohmann H.B., Gilchrist J.E., Babiuk L.A.: Effect of recombinant DNA-produced bovine interferon alpha (BoIFN-alpha 1) on the interaction between bovine alveolar macrophages and bovine herpesvirus type 1. J Gen Virol 1984, 65, 1487–1495, doi: 10.1099/0022-1317-65-9-1487.OhmannH.B.GilchristJ.E.BabiukL.A.Effect of recombinant DNA-produced bovine interferon alpha (BoIFN-alpha 1) on the interaction between bovine alveolar macrophages and bovine herpesvirus type 119846514871495doi10.1099/0022-1317-65-9-14876470681Open DOISearch in Google Scholar
Organisation for Economic Co-operation and Development: Test No. 407: Repeated Dose 28-day Oral Toxicity Study in Rodents, OECD Guidelines for the Testing of Chemicals, Section 4. OECD Publishing, Paris, 2008, doi: 10.1787/9789264070684-en.OECD PublishingParis2008doi10.1787/9789264070684-enOpen DOISearch in Google Scholar
Shin J.-H., Moon H.-J., Kim T.-S., Kang I.H., Ki H.Y., Choi K.-S., Han S.-Y.: Repeated 28-day oral toxicity study of vinclozolin in rats based on the draft protocol for the “Enhanced OECD Test Guideline No. 407” to detect endocrine effects. Arch Toxicol 2006, 80, 547–554, doi: 10.1007/s00204-006-0080-6.ShinJ.-H.MoonH.-J.KimT.-S.KangI.H.KiH.Y.ChoiK.-S.HanS.-Y.Repeated 28-day oral toxicity study of vinclozolin in rats based on the draft protocol for the “Enhanced OECD Test Guideline No. 407” to detect endocrine effects200680547554doi10.1007/s00204-006-0080-616489464Open DOISearch in Google Scholar
Tabarraei H., Hassan J., Parvizi M.R., Golshahi H., Keshavarz-Tarikhi H.: Evaluation of the acute and sub-acute toxicity of the black caraway seed essential oil in Wistar rats. Toxicol Rep 2019, 6, 869–874, doi: 10.1016/j.toxrep.2019.08.010.TabarraeiH.HassanJ.ParviziM.R.GolshahiH.Keshavarz-TarikhiH.Evaluation of the acute and sub-acute toxicity of the black caraway seed essential oil in Wistar rats20196869874doi10.1016/j.toxrep.2019.08.010671928431497509Open DOISearch in Google Scholar
Thivolet J., Nicolas J.F., Kanitakis J., Lyonnet S., Chouvet B.: Recombinant interferon alpha 2a is effective in the treatment of discoid and subacute cutaneous lupus erythematosus. Br J Dermatol 1990, 122, 405–409, doi: 10.1111/j.1365-2133.1990.tb08290.x.ThivoletJ.NicolasJ.F.KanitakisJ.LyonnetS.ChouvetB.Recombinant interferon alpha 2a is effective in the treatment of discoid and subacute cutaneous lupus erythematosus1990122405409doi10.1111/j.1365-2133.1990.tb08290.x2182099Open DOISearch in Google Scholar
Tu Y.B., Wang G., Wang Y.-Q., Chen W.-Y., Zhang L., Liu Y.-G., Jiang C.-G., Wang S.-J., Bu Z.-G., Cai X.-H.: Extracellular expression and antiviral activity of a bovine interferon-alpha through codon optimization in Pichia pastoris. Microbiol Res 2016, 191, 12–18, doi: 10.1016/j.micres.2016.05.009.TuY.B.WangG.WangY.-Q.ChenW.-Y.ZhangL.LiuY.-G.JiangC.-G.WangS.-J.BuZ.-G.CaiX.-H.Extracellular expression and antiviral activity of a bovine interferon-alpha through codon optimization in Pichia pastoris20161911218doi10.1016/j.micres.2016.05.00927524649Open DOISearch in Google Scholar
Van Wyk B., Snider M., Scruten E., Littel-van den Hurk S.V., Napper S.: Induction of functional interferon alpha and gamma responses during acute infection of cattle with non-cytopathic bovine viral diarrhea virus. Vet Microbiol 2016, 195, 104–114, doi: 10.1016/j.vetmic.2016.09.015.VanWyk B.SniderM.ScrutenE.Littel-van den HurkS.V.NapperS.Induction of functional interferon alpha and gamma responses during acute infection of cattle with non-cytopathic bovine viral diarrhea virus2016195104114doi10.1016/j.vetmic.2016.09.01527771055Open DOISearch in Google Scholar
Vilar Gomez E., Grá Oramas B., Arús Soler E., Ruenes Domech C., Davila Gonzalez Y.: Sequential combination therapy with prednisone, lamivudine and interferon alfa-2b for HBeAg-positive chronic hepatitis B. Gastroenterol Hepatol 2006, 29, 534–541.Vilar GomezE.Grá OramasB.Arús SolerE.Ruenes DomechC.Davila GonzalezY.Sequential combination therapy with prednisone, lamivudine and interferon alfa-2b for HBeAg-positive chronic hepatitis B20062953454110.1157/1309434817129547Search in Google Scholar
Wahid B., Shami K., Joiya S.A., Ozuyar S.E.G., Idrees M.: Comparing the risk of hypothyroidism in HCV patients treated with different DAA drugs combinations (sofosbuvir + interferon + ribavirin and sofosbuvir + daclatasvir + ribavirin). J Med Virol 2020, 92, 3868–3870, doi: 10.1002/jmv.25931.WahidB.ShamiK.JoiyaS.A.OzuyarS.E.G.IdreesM.Comparing the risk of hypothyroidism in HCV patients treated with different DAA drugs combinations (sofosbuvir + interferon + ribavirin and sofosbuvir + daclatasvir + ribavirin)20209238683870doi10.1002/jmv.2593132419178Open DOISearch in Google Scholar
Walder C.E., Thiemermann C., Vane J.R.: Endothelium-derived relaxing factor participates in the increased blood flow in response to pentagastrin in the rat stomach mucosa. Proc Biol Sci 1990, 241, 195–200, doi: 10.1098/rspb.1990.0085.WalderC.E.ThiemermannC.VaneJ.R.Endothelium-derived relaxing factor participates in the increased blood flow in response to pentagastrin in the rat stomach mucosa1990241195200doi10.1098/rspb.1990.00851979444Open DOISearch in Google Scholar
Yu H.-Y., Liu J., He Z.-Y., Zhou W., Xia B.-B., Wang M., Chen J., Wang M.-L., Jiang G.-T., Zhao J.: Soluble Expression, Rapid Purification and Antiviral Activity of Recimbinant Bovine Interferon-α in Escherichia coli. Appl Biochem Microbiol 2020, 56, 154–163, doi: 10.1134/S0003683820020143.YuH.-Y.LiuJ.HeZ.-Y.ZhouW.XiaB.-B.WangM.ChenJ.WangM.-L.JiangG.-T.ZhaoJ.Soluble Expression, Rapid Purification and Antiviral Activity of Recimbinant Bovine Interferon-α in Escherichia coli202056154163doi10.1134/S0003683820020143Open DOISearch in Google Scholar
Zhao J., Yu H.Y., Zhang J.L., Wang X.M., Li J.P., Hu T., Hu Y., Wang M.L., Shen Y.Z., Xu J.D., Han G.X., Chen J.: Pharmacokinetic studies of the recombinant chicken interferon-alpha in broiler chickens. J Vet Med Sci 2017, 79, 314–319, doi: 10.1292/jvms.15-0681.ZhaoJ.YuH.Y.ZhangJ.L.WangX.M.LiJ.P.HuT.HuY.WangM.L.ShenY.Z.XuJ.D.HanG.X.ChenJ.Pharmacokinetic studies of the recombinant chicken interferon-alpha in broiler chickens201779314319doi10.1292/jvms.15-0681532693627890904Open DOISearch in Google Scholar